GreenSky is pleased to start our relationship with Cyclica Inc, a pioneer in the development of next generation in silico discovery and testing technologies. Cyclica’s platform reduces the failure risk of drug discovery projects by allowing clients to anticipate a drug candidate’s side effects prior to clinical trials, thereby enabling more informed R&D investment decisions.